GSK homepage Introducing GSK Downloads Annual report


Internet

Information for investors and about the company is available from our
corporate homepage:






United Kingdom

Investor Relations - Europe
Glaxo Wellcome House
Berkeley Avenue
Greenford
Middlesex UB6 0NN
Tel: +44 (0)20 8966 8401/8298
Fax: +44 (0)20 8966 8587

Registrar
Lloyds TSB Registrars
The Causeway
Worthing
West Sussex BN99 6DA
Tel: +44 (0)1903 833 960 General enquiries
Tel: +44 (0)1903 854 287 DRIP enquiries
Tel: +44 (0)870 242 4244 ISA enquiries
Tel: +44 (0)1903 833 412 Annual Report orderline

Glaxo Wellcome corporate PEPs
The Share Centre Limited
Oxford House
Oxford Road
Aylesbury
Bucks HP21 8SZ
Tel: +44 (0)1296 414 144

Corporate share dealing facility
NatWest Stockbrokers
Corporate & Employee Service
55 Mansell Street
London E1 8AN
Tel: +44 (0)870 600 3080
Tel: +44 (0)20 7895 5923

 

 


Head Office and Registered Office

GlaxoSmithKline plc
Glaxo Wellcome House
Berkeley Avenue
Greenford
Middlesex UB6 0NN
Tel: +44 (0)20 8966 8000
Fax: +44 (0)20 8966 8330


United States of America

Investor Relations
One Franklin Plaza
PO Box 7929
Philadelphia
Tel: +1 215 751 7003
Fax: +1 215 751 3233

ADR programme administrator
The Bank of New York
Shareholder Relations
PO Box 11258
Church Street Station
New York NY 10286-1258
Tel: +1 877 353 1154 toll free
Tel: +1 908 769 9835 outside the USA

Customer Response Center
Tel: +1 888 825 5249 toll free

  Product names throughout this publication are indicated in italics and are trade marks of GlaxoSmithKline plc, its subsidiaries or associated companies, with the exception of Nicoderm which is a trademark of Hoechst Marion Roussel Inc and Coreg which is a trademark under licence from Roche Laboratories Inc.
     
  Back to top
  Updated March 22, 2001 - © 2001-2002 GlaxoSmithKline - All Rights Reserved
Legal Notices
- Privacy Statement
Introducing GSK
Chairman and CEO
Business operating review
Corporate citizenship
Product portfolio
Corporate executive team
Summary financials
Summary remuneration report
Responsibility statements
Corporate governance
The board
Shareholder return
Shareholder information
Contact details